Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice
暂无分享,去创建一个
E. Farrow | K. White | A. Robling | M. Allen | M. Peacock | R. Chan | Xijie Yu | S. Hui | J. Fleet | R. Vidal | H. Garringer | Charles B. Goodwin | K. R. Stayrook | S. I. Davis | Martin J Magers | Lelia J Summers | V. Jideonwo | M. Magers | M. Allen | Lelia J. Summers
[1] Leah R. Padgett,et al. Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans. , 2011, The Journal of clinical endocrinology and metabolism.
[2] E. Farrow,et al. Altered renal FGF23-mediated activity involving MAPK and Wnt: effects of the Hyp mutation. , 2010, The Journal of endocrinology.
[3] W. Holzgreve,et al. Diagnosis and treatment of iron-deficiency anaemia during pregnancy and postpartum , 2010, Archives of Gynecology and Obstetrics.
[4] M. Gribaa,et al. An autosomal dominant hypophosphatemic rickets phenotype in a Tunisian family caused by a new FGF23 missense mutation , 2010, Journal of Bone and Mineral Metabolism.
[5] T. Fujita,et al. Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia. , 2009, Bone.
[6] C. Frampton,et al. FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study. , 2009, The Journal of clinical endocrinology and metabolism.
[7] E. Farrow,et al. Initial FGF23-mediated signaling occurs in the distal convoluted tubule. , 2009, Journal of the American Society of Nephrology : JASN.
[8] M. Doogue,et al. Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia , 2009, Annals of clinical biochemistry.
[9] W. Fraser,et al. The association of circulating ferritin with serum concentrations of fibroblast growth factor-23 measured by three commercial assays , 2007, Annals of clinical biochemistry.
[10] V. Nizet,et al. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). , 2007, The Journal of clinical investigation.
[11] Siu L. Hui,et al. FGF23 Concentrations Vary With Disease Status in Autosomal Dominant Hypophosphatemic Rickets , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[12] K. Okawa,et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23 , 2006, Nature.
[13] L. Bonewald,et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism , 2006, Nature Genetics.
[14] T. Strom,et al. DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis , 2006, Nature Genetics.
[15] Xi Jiang,et al. Pathogenic role of Fgf23 in Hyp mice. , 2006, American journal of physiology. Endocrinology and metabolism.
[16] K. Rosenblatt,et al. Regulation of Fibroblast Growth Factor-23 Signaling by Klotho* , 2006, Journal of Biological Chemistry.
[17] C. Cutler,et al. Iron loading into ferritin can be stimulated or inhibited by the presence of cations and anions: a specific role for phosphate. , 2005, Journal of inorganic biochemistry.
[18] S. Mooney,et al. Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed. , 2005, Endocrinology.
[19] H. Tenenhouse. Regulation of phosphorus homeostasis by the type iia na/phosphate cotransporter. , 2005, Annual review of nutrition.
[20] Jerry Kaplan,et al. Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004, Science.
[21] M. Razzaque,et al. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. , 2004, Matrix biology : journal of the International Society for Matrix Biology.
[22] C. Ohlsson,et al. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. , 2004, Endocrinology.
[23] Y. Takeuchi,et al. FGF‐23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[24] S. Fukumoto,et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. , 2003, The New England journal of medicine.
[25] L. Quarles,et al. Serum FGF23 Levels in Normal and Disordered Phosphorus Homeostasis , 2003, Journal of Bone and Mineral Research.
[26] K. Eckardt,et al. Activation of the hypoxia‐inducible factor pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] C. Jun,et al. Involvement of p38 MAP kinase during iron chelator-mediated apoptotic cell death. , 2002, Cellular immunology.
[28] Y. Takeuchi,et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. , 2002, The Journal of clinical endocrinology and metabolism.
[29] T. Yoneya,et al. Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. , 2002, Endocrinology.
[30] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[31] T. Strom,et al. Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. , 2001, Kidney international.
[32] S. Takeda,et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[33] T. Meitinger,et al. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 , 2000, Nature Genetics.
[34] M. Shiraki,et al. Saccharated ferric oxide-induced osteomalacia in Japan: iron-induced osteopathy due to nephropathy. , 1998, Endocrine journal.
[35] T. Kobayashi,et al. Saccharated ferric oxide (SFO)-induced osteomalacia: in vitro inhibition by SFO of bone formation and 1,25-dihydroxy-vitamin D production in renal tubules. , 1997, Bone.
[36] M. Econs,et al. Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder. , 1997, The Journal of clinical endocrinology and metabolism.
[37] G. Semenza,et al. Structural and functional analysis of hypoxia-inducible factor 1. , 1997, Kidney international.
[38] K. Bitar,et al. Regulation of smooth muscle contraction in rabbit internal anal sphincter by protein kinase C and Ins(1,4,5)P3. , 1991, The American journal of physiology.
[39] W. Goodman,et al. Transferrin enhances the antiproliferative effect of aluminum on osteoblast-like cells. , 1991, The American journal of physiology.
[40] W. Goodman,et al. Characterization of the transferrin receptor in UMR-106-01 osteoblast-like cells. , 1990, Endocrinology.
[41] R. Morris,et al. Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men. , 1989, The Journal of clinical investigation.
[42] M. Drezner,et al. Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[43] Y. Ohira,et al. Effects of dietary iron deficiency on muscle fiber characteristics and whole-body distribution of hemoglobin in mice. , 1983, The Journal of nutrition.
[44] F. Glorieux,et al. Relation between hypomineralized periosteocytic lesions and bone mineralization in vitamin D-resistant rickets , 1983, Calcified Tissue International.
[45] Harrison He,et al. Familial hypophosphatemic rickets showing autosomal dominant inheritance. , 1971 .
[46] D. Burr,et al. Morphological Assessment of Basic Multicellular Unit Resorption Parameters in Dogs Shows Additional Mechanisms of Bisphosphonate Effects on Bone , 2009, Calcified Tissue International.
[47] G. Tompkins,et al. The Effects of Dietary Ferric Iron and Iron Deprivation on the Bacterial Composition of the Mouse Intestine , 2001, Current Microbiology.
[48] J. Bianchine,et al. Familial hypophosphatemic rickets showing autosomal dominant inheritance. , 1971, Birth defects original article series.